Generation of a highly versatile TCR bispecific scaffold optimized for targeting tumor-specific peptide-HLA antigens. [PDF]
Hofmann M +16 more
europepmc +1 more source
Fc-engineering for improved cancer immunotherapy. [PDF]
Borgman E +3 more
europepmc +1 more source
An IgG-like fusion protein comprising an anti-spike S2 antibody and ACE2 exhibits potent and broad neutralization against SARS-CoV-2 and variants of concern. [PDF]
Wei Z +17 more
europepmc +1 more source
Tyrosine Kinase Inhibitors, Antibody-Drug Conjugates, and Bispecific Antibodies in Oncogene-Driven Non-Small-Cell Lung Cancer: Evolving Roles in Treatment Sequencing and Resistance Management. [PDF]
Musleh Ud Din S +4 more
europepmc +1 more source
Advances in Bispecific Antibodies and Antibody-Drug Conjugates for Colorectal Cancer Treatment. [PDF]
Cappellino MG +4 more
europepmc +1 more source
Fc-Silenced CD89 × EGFR Bispecific Antibodies Promote Neutrophil and Macrophage Antitumor Activity. [PDF]
Meiser F +5 more
europepmc +1 more source
12th Immunotherapy of Cancer Conference (ITOC12): A meeting report. [PDF]
Jang S +5 more
europepmc +1 more source
Durable CNS remission with elranatamab and intrathecal therapy in relapsed/refractory multiple myeloma. [PDF]
Mersin S, Sevindik ÖG.
europepmc +1 more source
Expanding Biolayer Interferometry Applications: Enhanced Accuracy, Precision, and Sensitivity in Residual Biomolecule Detection and Quantitation of Bispecifics and AAV Viral Particles. [PDF]
Knowling S, McBain K, Apiyo D.
europepmc +1 more source
T-Cell Engagers Targeting <i>BCMA</i>, <i>GPRC5D</i>, or <i>FcRH5</i> in Relapsed/Refractory Multiple Myeloma: The Landscape Beyond CAR-T Cell Therapy-A Systematic Review and Network Meta-Analysis. [PDF]
Shambhavi S +7 more
europepmc +1 more source

